WallStSmart
THC

Tenet Healthcare Corporation

NYSE: THC · HEALTHCARE · MEDICAL CARE FACILITIES

$177.12
-1.65% today

Updated 2026-04-30

Market cap
$15.78B
P/E ratio
11.62
P/S ratio
0.74x
EPS (TTM)
$15.50
Dividend yield
52W range
$145 – $247
Volume
1.2M

Tenet Healthcare Corporation (THC) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+29.1%
Last 4 quarters
Revenue YoY growth
+9.0%
Most recent quarter
EPS YoY growth
+36.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+8.5%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+20.3%
2026-02-11
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-11$4.70+16.9%$193.04$232.26+20.3%
2025-10-28$3.70+10.8%$216.17$209.14-3.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$4.02$4.70+16.9%$5.53B+9.0%
2025-09-30$3.34$3.70+10.8%$5.29B+3.3%
2025-06-30$2.66$4.02+51.1%$5.27B+3.3%
2025-03-31$3.17$4.36+37.5%$5.22B-2.7%
2024-12-31$2.83$3.44+21.5%$5.07B-5.7%
2024-09-30$2.37$2.93+23.6%$5.12B+1.1%
2024-06-30$1.90$2.31+21.6%$5.10B+0.4%
2024-03-31$1.43$3.22+125.2%$5.37B
2023-12-31$1.60$2.68+67.5%$5.38B
2023-09-30$1.20$1.44+20.0%$5.07B
2023-06-30$1.25$1.44+15.2%$5.08B

Frequently asked questions

Has Tenet Healthcare Corporation beaten earnings estimates?
Tenet Healthcare Corporation has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +29.1% over the last 4 quarters.
How does THC stock react to earnings?
THC stock has moved an average of +8.5% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Tenet Healthcare Corporation's revenue growth rate?
Tenet Healthcare Corporation reported year-over-year revenue growth of +9.0% in its most recent quarter, with EPS growing +36.6% year-over-year.